NYLIM
GILD icon

New York Life Investment Management’s Gilead Sciences GILD Stock Holding History

New York Life Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3M Sell
184,378
-797
-0.4% -$105K 0.16% 114
2026
Q1 		$25.8M Buy
185,175
+5,022
+3% +$703K 0.22% 86
2025
Q4 		$22.1M Sell
180,153
-994
-0.5% -$121K 0.19% 108
2025
Q3 		$20.1M Sell
181,147
-6,424
-3% -$730K 0.18% 109
2025
Q2 		$20.8M Buy
187,571
+789
+0.4% +$84K 0.19% 101
2025
Q1 		$20.9M Sell
186,782
-1,396
-0.7% -$144K 0.21% 98
2024
Q4 		$17.4M Buy
188,178
+1,942
+1% +$175K 0.17% 116
2024
Q3 		$15.6M Sell
186,236
-6,006
-3% -$458K 0.15% 137
2024
Q2 		$13.2M Buy
192,242
+1,965
+1% +$131K 0.13% 156
2024
Q1 		$13.9M Sell
190,277
-6,539
-3% -$503K 0.14% 142
2023
Q4 		$15.9M Sell
196,816
-27,356
-12% -$2.13M 0.16% 121
2023
Q3 		$16.8M Sell
224,172
-6,022
-3% -$463K 0.18% 110
2023
Q2 		$17.7M Sell
230,194
-2,297
-1% -$183K 0.18% 114
2023
Q1 		$19.3M Sell
232,491
-19,284
-8% -$1.6M 0.21% 105
2022
Q4 		$21.6M Sell
251,775
-1,442
-0.6% -$114K 0.25% 89
2022
Q3 		$15.6M Sell
253,217
-3,358
-1% -$212K 0.19% 119
2022
Q2 		$15.9M Buy
+256,575
New +$15.9M 0.18% 115

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

New York Life Investment Management's GILD Position: Q2 2026 in Review

New York Life Investment Management reduced its Gilead Sciences (GILD) stake by 0.43% in Q2 2026, selling an estimated $105K and leaving 184,378 shares worth $23.3M. The position accounts for 0.16% of the portfolio, ranked #114.

New York Life Investment Management first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $25.8M in Q1 2026. 1,757 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • New York Life Investment Management held 184,378 shares of Gilead Sciences worth $23.3M as of Q2 2026.
  • New York Life Investment Management sold 797 Gilead Sciences shares in Q2 2026, an estimated $105K.
  • Gilead Sciences made up 0.16% of New York Life Investment Management's portfolio in Q2 2026, its #114 holding.
  • New York Life Investment Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Gilead Sciences position peaked at $25.8M in Q1 2026.
  • 1,757 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.